CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NVS

Pertuzumab

Phase 3
Novartis AG (NVS)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Feb '27
NVSPhase 3

Pertuzumab Phase 3 Est. Readout

Pertuzumab
Feb 2027~
CT.gov
00%
Competitive Landscape

0 competitors in Advanced HER2+Breast Cancer

View Full Landscape
Drug Information

Target Indication

Advanced HER2+Breast Cancer

Clinical Trial

NCT04208178

Last updated: 1/24/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.